423 results
Page 2 of 22
8-K
EX-10.2
dagvb21p0gz
27 Mar 20
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
r9qwpfy7hy833e4x
27 Mar 20
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-99.1
8g48y
16 Mar 20
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
4:17pm
8-K
EX-99.1
1lbb4
18 Feb 20
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership
4:00pm
424B3
qig9pmib3pabdp pg2md
30 Jan 20
Prospectus supplement
5:09pm
8-K
EX-99.1
94buh
14 Jan 20
Precipio announces shareholder update call to kick off 2020
2:24pm
8-K
EX-99.1
ouqqq5wim
4 Dec 19
Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors
4:01pm
8-K
EX-99.1
whb2 piwsa5lzyq
5 Nov 19
Precipio Announces Q3-2019 Corporate Update Call for Shareholders
4:00pm
8-K
EX-99.1
x2orw3dwcopvxh
3 Oct 19
Precipio announces shareholder update call on commercial progress
12:00am
8-K
EX-99.1
73smq93cp9p updku
26 Sep 19
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
4:43pm
424B3
rqoqhxzm26llu ws
21 Aug 19
Prospectus supplement
5:28pm
8-K
EX-99.1
6bzpikii77gwcb
14 Aug 19
Precipio Announces Q2-2019 Corporate Update Call for Shareholders
12:00am